Driving breakthroughs for the NF community at the 2025 NF Conference

A new era is unfolding for the NF community. With two FDA-approved treatments now on the market – including the first-ever therapy for adults with NF1 – and cutting-edge advances in AI, drug repositioning, and precision medicine,…